Press Release
The Study “Effect of Cold Atmospheric Plasma on SARS‐CoV‐2”
We're so proud to announce that the study our colleagues CEO Constantinos Loizou and Lab Director Theofylaktos Apostolou have been working on has been published in COVID peer-reviewed journal by one of the biggest academic publisher MDPI. The study "Effect of Cold...
EBRD Starventure event in Athens
Starventure program from EBRD allowed Embio Diagnostics Ltd to get from Start-up to Scale-Up! Our mission evolved to revolutionize the world of Indoor Air Quality. On Thrusday 22/09 in Athens CEO and Founder of Embio Diagnostics Constantinos Loizou shared his...
PASCAL school visit
Pascal school senior students were able to put theory into practice during their visit at EMBIO Diagnostics laboratories. It was possible as EMBIO, is going though all stages of producing medical devices – from developing ideas, research and tests. A tour through...
“Future of Retail 2022” Conference of ESEE
EMBIO Diagnostics has been fortunate to be invited attendant at "Future of Retail 2022" Conference of ESEE in Athens. It has been a great experience to discuss and feature digitization and sustainable transition of the economy sphere and retail itself. As also to...
Ballast Water Solutions: When Innovation Breeds Innovation
Two Cypriot startups, EMBIO Diagnostics and Ag Catalytic Solutions, joined forces to bring to life a Maritime / Shipping disruptive innovation that is set to change the face of marine biodiversity. Discharging ballast water in the oceans and seas, releases pathogenic...
DIACTMOND project: presenting final prototype
Huge news on DIACTMOND PROJECT: we are happy to announce that we reached final phase of the work on DIACTMOND PROJECT – after successful testing in collaboration with our clinical partners at the Nicosia General Hospital, Embio Diagnostics’ scientists presented a...